Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes

Inclusion Criteria: * Clinical diagnosis of type 1 diabetes for at least 1 year without significant endogenous insulin production * Currently using insulin pump * Understanding and willingness to follow the protocol and sign informed consent. * Willingness to sign a consent for release of medical information at the time of enrollment * Ability to speak, read and write in the language of the investigators. Exclusion Criteria: * History of DKA or severe hypoglycemia within the past 6 months * eGFR \<45 mL/min/1.73 m2 or other significant renal impairment * Pregnancy or breastfeeding * Current use of non-insulin medications affecting ketone production, including SGLT2 inhibitors * Active skin infections or conditions affecting sensor application sites * Known skin allergies to tapes or adhesives * Current use of any long-acting insulin analogs * A known medical condition that in the judgment of the investigator might interfere with the completion of the protocol